Aurobindo Pharma informs about revised presentation

10 Feb 2026 Evaluate

Aurobindo Pharma has informed that it attached the revised presentation that would be used in the investors / analysts call on Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025 to be held today, February 10, 2026 at 8.30 am. The revised presentation is also being uploaded to the following weblink of the Company. https://www.aurobindo.com/investors/disclosures-under-regulation-46/investor-meet/presentations.


The above information is a part of company’s filings submitted to BSE. 

Aurobindo Pharma Share Price

1279.30 -12.10 (-0.94%)
23-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1756.35
Dr. Reddys Lab 1252.55
Cipla 1222.70
Zydus Lifesciences 860.55
Lupin 2297.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×